Sitala Bio
Pre-clinicalOur immune systems evolved to deal with infections, which were a leading cause of illness and death. As we now live much longer, our immune systems begin to trigger chronic, low-grade inflammation. This then drives inflammatory diseases in the brain and body.
Founded
2021
Focus
Small Molecules
About
Our immune systems evolved to deal with infections, which were a leading cause of illness and death. As we now live much longer, our immune systems begin to trigger chronic, low-grade inflammation. This then drives inflammatory diseases in the brain and body.
Funding History
1Total raised: $3.5M
Seed$3.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile